Register for OBGYN.net Editorial Advisor
Osteoporosis
Richard D. Wasnich, M.D.
- USA
Index
of Articles by Dr. Wasnich
Web Site: http://www.medsurf.com
Education
Johns Hopkins University, Baltimore
Maryland B.A. 1964
Johns Hopkins University, School of Medicine M.D. 1967
Post-Graduate Training
Internship in Medicine, Bellevue
Hospital, New York, 1967-68
New York
Residency in Medicine, Bellevue
Hospital and New York 1968-69
University Medical Center
Resident in Nuclear Medicine, Stanford University 1971-73
Chief Resident in Nuclear Medicine, Stanford University 1972-73
Certification and Professional Membership
American Board of Nuclear Medicine
1974
Fellow, American College of Physicians 1985
Diplomat, National Board of Medical Examiners 1967
American College of Nuclear Physicians
Society of Nuclear Medicine
Johns Hopkins Medical and Surgical Association
American Medical Association
Awards
Robert Reid Newell Award, Stanford
University 1973
Governors Award, American College of Physicians (Hawaii) 1983, 1987
Distinguished Physician Award - Society for Clinical Densitometry 1996
Offices
President, Hawaii Chapter, Society of Nuclear Medicine 1975, 1981-83
Current Appointments
Executive Director, Mana Institute
1990-current
Clinical Professor of Medicine, University of Hawaii, 1989-current
School of Medicine, Honolulu, Hawaii
Director, Hawaii Osteoporosis Center, Honolulu, Hawaii 1981-current
President, Hawaii Osteoporosis Foundation 1986-current
Publications
Journal articles: 146
Book Chapters: 2
Books: 2
Journal Articles
1. Wasnich R, Grumet C, Payne R, Kriss J. The occurrence of Graves' opthalmopathy folllowing external neck x-irradiation. J. Clin Endocrinol Metab 37:703, 1973.
2. Hansen R, Wasnich R, DeVries P, Sunshine P. Bile ascites in infancy; report with I-131 Rose Bengal Studies. J Pediatrics 84:719, 1974.
3. Berndt T, Alderman AL, Wasnich R, Hsieh SC, Van Dyke D, Harrison DC. Evaluation of a portable radionuclide method for measurement of left ventricular ejection fraction. J Nucl Med 16(April):289, 1974.
4. Shettigar UR, Hultgren HN, Berndt T, Wasnich RD. Occult atrial septal defect in adults. Chest 68(September):307, 1975.
5. Porter B, Wasnich R. Pulmonary embolism in Hawaii: an ethnic study. Hawaii Med J 34(December):421, 1975.
6. Wasnich R. A high-frequency ultrasonic nebulizer system for radioaerosol delivery. J Nucl Med Tech 17:707, 1976.
7. Teruya K, Yeh F, Porter J, Wasnich R. Technical facets of radioaerosol delivery. J Nucl Med Tech 4:126, 1976.
8. Wasnich R, Yamauchi S. Demonstration of lymphaticovenous communication in filariasis using radionuclide lymphoscintigraphy. Proceedings of the VIth International Congress of Lymphology. Georg Thieme Publishers, Stuttgart, pp 437-440, 1977.
9. Wasnich R, Glober G, Hayashi T, Vicher T, Yeh F. Computer quantitation of spleen/liver ratios in the diagnosis of hepatocellular disease. J Nucl Med 20:149, 1979.
10. Wasnich R, Seto DSJ, Fukunaga F. Prevalence of antibodies to Hepatitis A and Hepatitis B in a hospital population. Hawaii Med J 38:129-131, 1979.
11. Wasnich R, Puapongsakorn R, Seto DSJ. Significance of antibody to Hepatitis B core antigen in a hemodialysis unit. West J Med 132:279-282, 1980.
12. Nomura A, Stemmerman GN, Wasnich RD. Presence of Hepatitis B surface antigen before primary hepatocellular carcinoma. JAMA 247:2247-2249, 1982.
13. Wasnich RD, Benfante RJ, Yano K, Heilbrun LK, Vogel JM. Thiazide effect on the mineral content of bone. N Engl J Med 309:344-347, 1983.
14. Wasnich RD, Yano K, Vogel JM. Postmenopausal bone loss at multiple skeletal sites: relationship to estrogen use. J Chronic Dis 36(11):781-790, 1983.
15. Williams JA, Wagner J, Wasnich RD, Heilbrun LK. The effect of long distance running upon appendicular bone mineral content. Med & Sci in Sports & Exercise 16(3):223-227, 1984.
16. Yano K, Wasnich RD, Vogel JM, Heilbrun LK. Bone mineral measurements among middle-aged and elderly Japanese residents in Hawaii. Am J Epidemiol 119(5):751-764, 1984.
17. Wasnich RD, Benfante R, Yano K, Heilbrun LK, Vogel JM. Thiazide effect on the mineral content of bone. Author's reply. Invest Radiol Nov/Dec:60-603, 1984.
18. Yano K, Heilbrun LK, Wasnich RD, Hankin JH, Vogel JM. The relationship between diet and bone mineral content of multiple skeletal sites in elderly Japanese-American men and women living in Hawaii. Am J Clin Nutr 42:877-888, 1985.
19. Wasnich RD, Vogel JM, Yano K, Ross PD. A review of the major findings of the Kuakini Osteoporosis Study. Hawaii Med J 44:309-312, 1985.
20. Heilbrun LK, Kagan A, Nomura A, Wasnich RD. The origins of epidemiologic studies of heart disease, cancer and osteoporosis among Hawaii Japanese. Hawaii Med J 44:294-296, 1985.
21. Wasnich RD, Ross PD, Vogel JM. Care of the Elderly. Letter to the Editor. N Engl J Med 313(5):325-6, 1985.
22. Vogel JM, Wasnich RD. Cost of gamma photon absorptiometry in management of osteoporosis. Letter to the Editor. J Nucl Med Nov., 1985.
23. Wasnich RD, Ross PD, Heilbrun LK, Vogel JM. Prediction of postmenopausal fracture risk with bone mineral measurements. Am J Obstet & Gynecol 153:745-51, 1985.
24. Wasnich RD, Vogel JM. Peripheral versus axial skeleton measurements in osteoporosis. Letter to the Editor. J Nucl Med 27(10):1649-50, 1986.
25. Wasnich RD, Ross PD, Heilbrun LK, Vogel JM, Yano, K, Benfante R. Differential effects of thiazide and estrogen upon bone mineral content and fracture prevalence. Obstet Gynecol 67(4):457-463, 1986.
26. Wasnich RD, Ross PD. Screening bone mass measurements. Letter to the Editor. Ann Intern Med 105(6):974, 1986.
27. Wasnich RD, Vogel JM. Os calcis results questioned. Letter to the Editor. Am J Obstet Gynecol 155:1144-1146, Nov. 1986.
28. Wasnich RD, Ross PD, Heilbrun LK, Vogel JM. Selection of the optimal skeletal site for fracture risk prediction. Clin Orthop Rel Res 216:262-269, 1987.
29. Ross PD, Wasnich RD, Heilbrun LK, Vogel JM. Definition of a spine fracture threshold based upon prospective fracture risk. Bone 8:271-278, 1987.
30. Wasnich RD. Fracture prediction with bone mass measurements. In: HK Genant (ed), Osteoporosis Update, University Press, Berkeley, pp 95-101, 1987.
31. Wasnich RD. Screening for osteoporosis: Pro. In: HK Genant (ed), Osteoporosis Update, University Press, Berkeley, pp 123-127, 1987.
32. Wasnich RD. Thiazides in osteoporosis. In: HK Genant (ed), Osteoporosis Update, University Press, Berkeley, pp 301-304, 1987.
33. Wasnich RD, Vogel JM, Ross PD. Evaluating a new approach to the "Osteoporosis Prone" woman. Geriatrics 42(4):86-92, 1987.
34. Wasnich RD, Hagino R, Ross PD. Osteoporosis: will the use of new technology increase or decrease health care costs? Hawaii Med J 46:199-200, 1987.
35. Wasnich RD. Osteoporosis Task Force Report, Study Report 2, Japan-US Conference on Aging, Tokyo, pp 145-150, January 1987.
36. Ross PD, Wasnich RD, MacLean CJ, Vogel JM. Prediction of individual lifetime fracture risk expectancy using bone mineral measurements. In: Osteoporosis 1987. C Christiansen, JS Johansen, BJ Riis (eds). Osteopress, Copenhagen, Denmark, pp 288-293, 1987.
37. Ross PD, Wasnich RD, Vogel JM. Magnitude of artifact errors in spine dual-photon absorptiometry measurements. In: Osteoporosis 1987. C Christiansen, JS Johansen, BJ Riis (eds). Osteopress, Copenhagen, Denmark, pp 389-391, 1987.
38. Wasnich RD, Ross PD, MacLean CJ, Davis JW, Vogel JM. A prospective study of bone mass measurements and spine fracture incidence. In: Osteoporosis 1987. C Christiansen, JS Johansen, BJ Riis (eds). Osteopress, Copenhagen, Denmark, pp 377-378, 1987.
39. Wasnich RD, Ross PD, MacLean CJ, Davis JW, Vogel JM. The relative strengths of osteoporotic risk factors in a prospective study of postmenopausal osteoporosis. In: Osteoporosis 1987. C Christiansen, JS Johansen, BJ Riis (eds). Osteopress, Copenhagen, Denmark, pp 394-395, 1987.
40. Vogel JM, Wasnich RD, Ross PD. Use of bone mineral measurements for prospective fracture risk assessment. In: Bone mineral measurements by photon absorptiometry: methodological problems. Dequeker J, Geusens P, Wahner HW (eds). Leuven University Press, Leuven, Belgium, pp 105-108, 1988.
41. Ross PD, Wasnich RD, Vogel JM. Detection of pre-fracture spinal osteoporosis using bone mineral absorptiometry. J Bone Min Res 3(1):1-11, 1988.
42. Ross PD, Wasnich RD, Vogel JM. Precision error in dual-photon absorptiometry related to source age. Radiology 166:523-527, 1988.
43. Ross PD, Wasnich RD, MacLean CJ, Hagino R, Vogel JM. A model for estimating the potential costs and savings of osteoporosis prevention strategies. Bone 9:337-347, 1988.
44. Delaplain CB, Ling MCC, Yeh F, Wasnich RD. Sequential dose injections. A new technique for 99mTc-colloid gastrointestinal bleeding studies. Clin Nuc Med 13:783-785, 1988.
45. Vogel JM, Wasnich RD, Ross PD. The clinical relevance of calcaneus bone mineral measurements: A review. Bone Mineral 5:35-58, 1988.
46. Wasnich RD. Fracture risk prediction with bone mass measurement. Recent Progress in Osteoporosis Research, vol. 4, Ed. H. Orimo: pp 23-35; Hakone, Japan, 1988.
47. Wasnich RD. International comparative study on the epidemiology and risk factors of osteoporosis. Recent Progress in Osteoporosis Research, vol. 4, Ed. H. Orimo: pp 41-46; Hakone, Japan, 1988.
48. Wasnich RD, Ross PD, MacLean CJ, Vogel JM, Davis JW. A comparison of single versus multi-site BMC measurements for assessment of spine fracture probability. J Nucl Med 30:1166-1171, 1989.
49. Ross PD, Heilbrun LK, Wasnich RD, Davis JW, Vogel JM. Methodologic issues in evaluating risk factors for osteoporotic fractures. J Bone Min Res 4:649-656, 1989.
50. Davis JW, Ross PD, Wasnich RD, MacLean CJ, Vogel JM. Comparison of cross-sectional and longitudinal measurements of age-related changes in bone mass. J Bone Min Res 4(3):351-357, 1989.
51. Ross PD, Orimo H, Wasnich RD, Vogel JM, MacLean CJ, Davis JW, Nomura A. Methodologic issues in comparing genetic and environmental influences on bone mass. Bone Mineral 7:67-77, 1989.
52. Nomura A, Wasnich RD, Heilbrun LK, Ross PD, Davis JW. Comparison of bone mass between Japan-born and U.S.-born Japanese subjects in Hawaii. Bone Mineral 6:213-223, 1989.
53. Davis JW, Vogel JM, Ross PD, Wasnich RD. Disease versus etiology: the distinction should not be lost in the analysis. J Nucl Med 30: 1273-1276, 1989.
54. Ross PD, Davis JW, Vogel JM, Wasnich RD. A critical review of bone mass and the risk of osteoporotic fractures. Calcif Tiss Int, 46:149-161, 1990.
55. Wasnich RD. Radionuclides in gastrointestinal bleeding. Advantages of Tc99m sulfur colloid. Radiology Reports 2:210-216, 1990.
56. Ross PD, Davis JW, Wasnich RD. Reporting fracture risk results. J Bone Miner Res 5(4):419, 1990.
57. Wasnich RD, Ross PD, Davis JW. Appropriate clinical application of bone mass measurements. J Am Med Women Assn 45:99-102, 1990.
58. Ross PD, Wasnich RD, Davis JW. Fracture prediction models for osteoporosis prevention. Bone 11:327-331, 1990.
59. Watts NB, Harris ST, Genant HK, Wasnich RD, Miller PD, Jackson RD, Licata AA, Ross PD, Woodson GC, Yanover M, Mysiw WJ, Kohse L, Rao MB, Steiger P, Richmond B, Chesnut CH. Intermittent cyclical Etidronate treatment of postmenopausal osteoporosis. N Engl J Med 323:73-79, 1990.
60. Wasnich RD, Davis JW, Ross PD, Vogel JM. Effect of thiazide on rates of bone mineral loss. A longitudinal study. Br Med J 301:1303-1305, 1990.
61. Wasnich RD. Osteoporosis Screening -- current status. Transitions 1(3):4-6, 1990.
62. Wasnich RD, Ross PD, Davis JW, Vogel JM. Etidronate regimen increases bone mass: a longitudinal comparison of skeletal sites. In: Osteoporosis 1990. C Christiansen, K Overgaard (eds). Osteopress ApS, Copenhagen, Denmark. pp1396-8, 1990.
63. Davis JW, Ross PD, Vogel JM, Wasnich RD. Post-menopausal estrogen use among Japanese-American women: patterns of use and effects on bone loss rates. Third International Symposium on Osteoporosis. Copenhagen, Denmark. pp 1099-1101, 1990.
64. Ross PD, Davis JW, Wasnich RD, Vogel JM. Optimizing treatment regimens for preventing osteoporosis. Third International Symposium on Osteoporosis. Copenhagen, Denmark. pp 1096-8, 1990.
65. Vogel JM, Davis JW, Ross PD, Wasnich RD. Uniformity of bone mineral content across eight skeletal measurement sites. Third International Symposium on Osteoporosis. Copenhagen, Denmark. pp 631-3, 1990.
66. Miller P, Watts N, Genant H, Wasnich R, Jackson R, Licata A, Chesnut C. The effects of cyclical etidronate on bone mass and fracture rate in postmenopausal osteoporosis: a three-year study. In: Osteoporosis 1990. C Christiansen, K Overgaard (eds). Osteopress ApS, Copenhagen, Denmark. pp 1403-1405, 1990.
67. Wasnich RD. Does current bone mass predict future fracture? In: Osteoporosis 1990. C Christiansen, K Overgaard (eds). Osteopress ApS, Copenhagen, Denmark. pp 442-445, 1990.
68. Ross PD, Wasnich RD, Davis JW. Letter to the Editor. J Bone Min Res 5:1273, 1990.
69. Ross PD, Wasnich,RD, Vogel JM. Detection of pre-fracture spinal osteoporosis using bone mineral absorptiometry. [Quoted and reprinted from J Bone Miner Res 3(1):1-11, 1988] Geriatrics Inter 1:74-77, 1990.
70. Heilbrun LK, Ross PD, Wasnich RD, Vogel JM, Yano KY. Characteristics of respondents and nonrespondents in a prospective study of osteoporosis. J Clin Epidemiol. 44(3):233-239, 1991.
71. Wasnich RD, Davis JW, Ross PD. Osteoporosis: current practice and future perspectives. Trends in endocrinology and metabolism 2:59-62, 1991.
72. Ross PD, Davis JM, Wasnich RD, Vogel JM. The clinical application of serial bone mass measurements. Bone Mineral 12:189-199, 1991.
73. Davis JW, Ross PD, Wasnich RD, MacLean CJ, Vogel JM. The long-term precision of bone loss rate measurements among postmenopausal women. Calcif Tissue Inter 48(5):311-318, 1991.
74. Ross PD, Wasnich RD, Davis JW, Vogel JM. Vertebral dimension differences between Caucasian populations, and between Caucasians and Japanese. Bone 12:107-112, 1991.
75. Ross PD, Norimatsu H, Davis JW, Yano K, Wasnich RD, Fujiwara S, Hosoda Y, Melton LJ III. A comparison of hip fracture incidence among native Japanese, Japanese-Americans, and American Caucasians. Am J Epidemiol 133(8):801-809, 1991.
76. Ross PD, Davis JW, Wasnich RD. Bone mass and fracture (letter to the editor). Calcif Tissue Inter, 48:144, 1991.
77. Ross PD, Ettinger B, Davis JW, Melton LJ III, Wasnich RD. Evaluation of adverse health outcomes associated with vertebral deformities. Osteoporosis International 1(3):134-140, 1991.
78. Ross PD, Ettinger B, Davis JW, Melton LJ III, Wasnich RD. Evaluation of adverse health outcomes associated with vertebral deformities. Osteoporosis International 1(3):134-140, 1991.
79. Ross PD, Davis JW, Epstein R, Wasnich RD. Pre-existing fractures and bone mass predict vertebral fracture incidence. Ann Intern Med 114(11):919-923, 1991.
80. Ross PD, Davis JW, Wasnich RD, Vogel JM. A critical review of bone mass and the risk of fractures in osteoporosis. [Quoted and reprinted from: Calcif Tissue Inter 46:149-161, 1990] Geriatr Int 2(5):10-13, 1991.
81. Davis JW, Ross PD, Vogel JM, Wasnich RD. Age-related changes in bone mass among Japanese-American men. Bone and Mineral 15:227-236, 1991.
82. Wasnich RD. Bone mass measurements in diagnosis and assessment of therapy. Am J Med supplement 19(5B):54S-58S, 1991.
83. Consensus Development Conference. Prophylaxis and treatment of osteoporosis. Osteoporosis Int 1(2):114-7, 1991.
84. Davis JW, Grove JS, Ross PD, Wasnich RD, Vogel JM. Relationship between bone mineral content and bone loss rate at appendicular skeletal sites. J Bone Miner Res 7(7):719-725, 1992
85. Wasnich RD. Diagnostic and Therapeutic Technology Assessment (DATTA): Measurement of Bone Density with Dual-Energy X-ray Absorptiometry (DEXA). JAMA 267(2):286-294, January 8, 1992.
86. He Y-F, Ross PD, Davis JW, MacLean CJ, Epstein RS, Wasnich RD. A method for estimating the uncertainty of future bone mass. Bone 13:243-247, 1992.
87. Ross PD, Davis JW, Wasnich RD. Prediction of fracture risk. Japan J Bone Miner Metab 10(1):52-62, 1992.
88. Wasnich RD, Ross PD, Davis JW, Vogel JM. US-Japan comparative studies of bone mass and fracture. Japan J Bone Miner Metab 10(1):49-51, 1992.
89. Ross PD, Davis JW, Epstein RS, Wasnich RD. Ability of vertebral dimensions from a single radiograph to identify new fractures. Calcif Tissue Inter 51:95-99, 1992.
90. Ross PD, Yhee YK, He Y-F, Davis JW, Kamimoto C, Epstein RS, Wasnich RD. A new method for vertebral fracture diagnosis. J Bone Miner Res 8(2):167-174, 1992.
91. He Y-F, Davis JW, Ross PD, Wasnich RD. Declining bone loss rate variability with increasing follow-up time. Bone Mineral 21:119-128, 1993.
92. Ross PD, Genant HK, Davis JW, Miller P, Wasnich RD. Predicting vertebral fracture incidence from prevalent fractures and bone density among non-black, osteoporotic women. Osteoporosis International 3(3):120-127, 1993.
93. Ross P, Yhee Y-K, Davis JW, Wasnich RD. Bone density predicts fracture incidence among elderly men. Fourth International Symposium on Osteoporosis. Handelstrykkeriet Aalborg ApS, Aalborg, Denmark, pp 190-91, 1993.
94. Ross PD, Davis JW, Wasnich RD. Bone mass and beyond: Risk factors for fractures. Calcif Tissue Inter 53(Suppl 1):S134-138, 1993.
95. Wasnich R. The value of risk factors for prediction of fracture risk. Proceedings of the Fourth International Symposium on Osteoporosis. Handelstrykkeriet Aalborg ApS, Aalborg, Denmark, pp 29-30, 1993.
96. Wasnich RD. Bone mass measurement: Prediction of risk. Am J Med 95(Suppl 5A): S6-S10, 1993.
97. Harris ST, Watts NB, Jackson RD, Genant HK, Wasnich RD, Ross P, Miller PD, Licata AA, Chesnut CH III. Four-year study of intermittent cyclic Etidronate treatment of postmenopausal osteoporosis: Three years of blinded therapy followed by one year of open therapy. Am J Med 95:557-567, 1993.
98. Wasnich RD. Selection of Postmenopausal Women for Pharmacologic Osteoporosis Intervention. Osteoporosis Int (1993) Suppl. 1:S70-71.
99. Davis JW, Ross PD, Wasnich RD. Evidence for both generalized and regional low bone mass among elderly women. J Bone Miner Res 9(3):305-309, 1994.
100. Ross PD, Davis JW, Epstein RS, Wasnich RD. Pain and disability associated with new vertebral fractures and other spinal conditions. J Clin Epidemiol 47(3):231-239, 1994.
101. Wasnich RD, Davis JW, Ross PD. Spine fracture risk is predicted by non-spine fractures. Osteoporosis Inter 4:1-5, 1994.
102. Cummings SR, Cauley J, Palermo L, Ross PD, Wasnich RD, Black D, Faulkner K. Racial differences in hip axis length might explain racial differences in rates of hip fracture. Osteo Intl 4(4):226-229, 1994.
103. He Y-F, Ross PD, Davis JW, Epstein RS, Vogel JM, Wasnich RD. When should bone density measurements be repeated? Calcif Tiss Int 55:243-248, 1994.
104. Davis JW, Novotny R, Ross PD, Wasnich RD. The peak bone mass of Hawaiian, Filipino, Japanese, and Caucasian women living in Hawaii. Calcif Tiss Int 55:249-252, 1994.
105. Davis JW, Ross PD, Wasnich RD. A longitudinal study of estrogen and calcium supplement use among Japanese women living in Hawaii. Prev Med 24(2):159-165 1995.
106. Ross PD, Huang C, Davis JW, Wasnich RD. Vertebral dimension measurements improve prediction of vertebral fracture incidence. Bone Miner 16(4)(Suppl):257S-262S, 1995.
107. Ross PD, He Y-F, Davis JW, Epstein RS, Wasnich RD. Normal ranges for bone loss rates. Bone Miner 26:169-180, 1994.
108. Davis JW, Ross PD, Wasnich RD. Relation of height and weight to the regional variations in bone mass among Japanese-American men and women. Osteo Intl 5:234-238, 1995.
109. Ross PD, Huang C, Davis JW, Imose K, Yates J, Vogel JM, Wasnich RD. Predicting vertebral deformity using bone densitometry at various skeletal sites and calcaneus ultrasound. Bone 16(3):325-332, 1995.
110. Wasnich RD, Davis JW, He Y-F, Petrovich H, Ross PD. A randomized, double masked, placebo-controlled trial of chlorthalidone and bone loss in elderly women. Osteop Intl 5:247-251, 1995.
111. Adami S, Ortolani S, Wasnich RD. Evaluation of Therapeutic Efficacy in Osteoporosis. Osteop Intl 5:75-78, 1995.
112. Taitano RT, Novotny R, Davis JW, Ross PD, Wasnich RD. Validity of a food frequency for the estimation of calcium intake among Japanese and Caucasian women. J Am Diet Assoc 95(7):804-6, 1995.
113. Ross PD, Fujiwara S, Huang C, Davis JW, Epstein RS, Wasnich RD, Kodama K, Melton LJ III. Japanese women in Hiroshima have greater vertebral fracture prevalence than Caucasians or Japanese-Americans in the US. Int J Epidemiol 24:1171-1177, 1995.
114. Davis JW, Ross PD, Johnson NE, Wasnich RD. Estrogen and calcium supplement use among Japanese-American women: effects upon bone loss when used singly and in combination. Bone 17(4):369-373, 1995.
115. Wasnich RD. The role of fracture risk assessment in osteoporosis prevention. Osteoporosis Japan 3(3):82(521)-92(532), 1995.
116. Novotny R, Davis JW, Ross PD, Wasnich RD. Adolescent milk consumption, menarche, birth weight, and ethnicity influence height of women in Hawaii. J Am Diet Assoc [in press]
117. Huang C, Ross PD, Davis JW, Wasnich RD. Contributions of vertebral fractures to stature loss among elderly Japanese-American women in Hawaii. J Bone Miner Res [in press]
118. Huang C, Ross PD, Fujiwara S, Davis JW, Epstein RS, Kodama K, Wasnich RD. Determinants of vertebral fracture prevalence among native Japanese women and women of Japanese descent living in Hawaii. Bone 18(5): , 1996 [in press].
119. Huang C, Ross PD, Wasnich RD. Vertebral fractures and other predictors of back pain among older women. J Bone Miner Res 1996 [in press]
120. Novotny R, Davis J, Ross P, Wasnich R. Adiposity and blood pressure in a multiethnic population in Hawaii. J Am Diet Assoc 1996 [in press]
121. Novotny, R., Davis, J., Ross, P., Wasnich, R.D. Adolescent milk consumption, menarche, birth weight, and ethnicity influence height of women in Hawaii. J Am Diet Assoc 805(3): 1996 [in press]
122. Ross PD, He Y-F, Yates AJ, Coupland C, Ravn P, McClung M, Thompson D, Wasnich RD, for the EPIC Study Group. Body size accounts for most differences in bone density between Asian and Caucasian women. Calcif Tiss Int 59:339-343, 1996.
123. Hla M, Davis JW, Ross PD, Wasnich RD, Yates AJ, Ravn P, Hosking D, McClung MR, EPIC Study Group. A multi-center study of the influence of fat and lean mass on bone mineral content: evidence for differences in their relative influence at major fracture sites. Am J Clin Nutr 64:354-60, 1996.
124. Huang C, Ross PD, Wasnich RD. Vertebral fracture and other predictors of physical impairment and health care utilization. Arch Intern Med 156:2469-2475, 1996.
125. Ross PD, Huang C, Karpf D, Lydick E, Coel M, Wasnich RD. Blinded reading of radiographs increases the frequency of errors in vertebral fracture diagnosis. J Bone Miner Res 11(11):1793-1800, 1996.
126. Watts N, Harris S, Genant H, Jackson R, Licata A, Miller P, Wasnich R, Chesnut C III. Clinical correlates of radiologically apparent vertebral fractures. Calcif Tiss Int 48(Suppl):A39, 1991.
127. Huang C, Ross PD, Lydick E, Wasnich RD. Factors associated with joint pain among postmenopausal women. Int J Obesity 21:349-354, 1997.
128 Davis JW, Ross PD, Nevitt MC, Wasnich RD. Incidence rates of falls among Japanese men and women living in Hawaii. J Clin Epidemiol 50(5):589-594, 1997.
129. Wasnich RD. Epidemiology of Osteoporosis in the United States of America. Osteoporosis Int 7 (Suppl. 3):S68-S72, 1997.
130. Fujiwara S, Huang C, Ross PD, Davis JW, Yamada M, Kodama K, Mabuchi K, Wasnich RD. Predictors of Osteoporosis Differ Between Native Japanese and Japanese-Americans, and Between Birth Cohorts. J Cross-Cultural Gerontol 1997 [in press]
131. Wasnich RD. Consensus and the T-score Fallacy. Clin Rheumatol 16(4), 1997 [in press]
132. Vogel JM, Davis JW, Nomura A, Ross PD, Wasnich RD. The effects of smoking on bone mass and the rates of bone loss among elderly Japanese-American men. J Bone Miner Res 12(9):, 1997.
133. Miller PD, Watts NB, Licata AA, Harris ST, Genant HK, Wasnich RD, Ross PD, Jackson RD, Hoseyni MS, Schoenfeld S, Valent DJ, Chesnut CH. Cyclical etidronate in the treatment of postmenopausal osteoporosis: efficacy and safety after 7 years of treatment. Amer Jrnl Med, 1997.
134. Davis JW, Ross PD, Preston SD, Nevitt MC, Wasnich RD. Strength, physical activity, and body mass index: relationship to performance based measures and activities of daily living among elderly Japanese women in Hawaii. [submitted]
135. Fujiwara S, et al. Serum 25-hydroxy vitamin D levels are lower in Japanese compared to Japanese in Hawaii. [in preparation]
136. Hosking DJ, Chilvers CED, Christiansen C, Ravn P, Wasnich R, Ross P, McClung M, Faulkner K, Yates J, Thompson D, Daley M. Prevention of early post-menopausal bone loss with oral alendronate.
137. Aoyagi K, Ross PD, Davis JW, Wasnich RD, Hayashi T, Takemoto T-I. Falls among community-dwelling elderly in Japan. [to be submitted].
138. Wasnich RD. Using the Internet to report remaining lifetime fracture probability (RLFP). Drug Info Jrnl 32, Nov 1998.
139. Davis JW, Grove JS, Wasnich RD, Ross PD. Spatial Relationships between Prevalent and Incident Spine Fractures. BONE [in press]
140. Wasnich, RD. Perspective on Fracture Risk and Phalangeal Bone Mineral Density. J of Clinical Densitometry, 1(3):259-268, Fall 1998.
141. Aoyagi K, Ross PD, Davis JW, Wasnich RD, Hayashi T, and Takemoto T. Falls among Community-Dwelling Elderly in Japan. J Bone Miner Res 13(9):1468-1474, 1998.
142. Wasnich RD. Don=t Wait for a Fracture. The Female Patient, 23:19-36, Oct 1998.
143. Hosking DJ, Ross PD, Thompson DE, Wasnich RD, McClung M, Bjarnason NH, Ravn P, Cizza G, Daley M, and Yates AJ. Evidence that Increased Calcium Intake Does Not Prevent Early Postmenopausal Bone Loss. Clin Therapeutics, 20(5):933-942, 1998.
144. Huang C, Ross PD, Yates AJ, Walker RE, Imose K, Emi K, Wasnich RD. Prediction of Fracture Risk by Radiographic Absorptiometry and Quantitative Ultrasound: A Prospective Study. Calcif Tissue Int 63:380-384, 1998.
145. Ravn P, Weiss S, Rodriguez-Portales J, McClung M, Wasnich, RD, Gilchrist N, Sambrook P, Fogelman I, Krupa D, Yates J, Daifotis A, Fuleihan HGE. Alendronate in Early Postmenopausal Women: Effects on Bone Mass during Long-Term Treatment and after Withdrawal. Ann Intern Med, Aug 1998.
146. Ravn P, Cizza G, Bjarnason NH, Thompson D, Daley M, Wasnich RD, McClung M, Hosking D, Yates JA, Christiansen C. Low Body Mass Index Is An Important Risk Factor for Low Bone Mass and Increased Bone Loss in Early Postmenopausal Women. J Bone Miner Res, August 1998.
Books
Phan Tran and Richard Wasnich. PRACTICAL NUCLEAR PHARMACY. Banyan Press, Honolulu, Hawaii, 1979, 2nd Edition, 1981; 3rd Edition, 1987.
Wasnich RD, Ross PD, Vogel JV, Davis JM. OSTEOPOROSIS - CRITIQUE AND PRACTICUM. Banyan Press, Honolulu, Hawaii, 1989.
Book Chapters
Wasnich RD. AWhat is an osteoporotic fracture?@. Chapter in: Osteoporosis. Diagnostic and Therapeutic Principles, Rosen C, ed. Current Clinical Practice Series, Humana Press, Inc., New Jersey. 1996
Wasnich RD. Epidemiology of Osteoporosis. In: Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 3rd Edition, Favus MJ (ed), Lippencott-Raven, Philadelphia, 1996, pp 249-251.
Abstracts
1. Wasnich R, Alderman E, Harrison DC, Van Dyke D. Evaluation of a portable radionuclide method for measurement of left ventricular ejection fraction. [abstract] Circulation 48:106, 1973.
2. Wasnich RD, Ross PD, Vogel JM. Evaluation of a screening test for fracture risk prediction: a prospective study of bone mineral content and fracture incidence. [abstract] Clin Nucl Med 10(9S):P16, 1985.
3. Wasnich RD, Ross PD, Heilbrun LK, Vogel JM. Methods of fracture risk prediction using bone mineral measurements. [abstract] J Bone Min Res 1(1):120, 1986.
4. Ross PD, Wasnich RD, Vogel JM, Heilbrun LK. Choice of a bone mineral measurement site based upon ability to predict fracture risk. [abstract] J Bone Min Res 1(1):122, 1986.
5. Wasnich RD, Ross PD, Vogel JM. A prospective study of multi-site bone mineral measurements and spine fracture incidence. [abstract] Clin Nucl Med 11(9S):P12, 1986.
6. Vogel JM, Ross PD, Wasnich RD. Os calcis bone mineral measurements. An evaluation of their clinical utility. [abstract] Clin Nucl Med 11(9S):P26, 1986.
7. Wasnich RD, Vogel JM, Ross PD, Heilbrun LK. Age-specific, longitudinal bone loss rates at multiple cortical and trabecular skeletal sites. [abstract] J Bone Min Res 1(Suppl 1):A245, 1986.
8. Ross PD, Wasnich RD, Vogel JM. A new definition of the fracture threshold. [abstract] J Bone Min Res 1(Suppl 1):A268, 1986.
9. Wasnich RD, Ross PD, Vogel JM. Prospective fracture risk assessment with multi-site bone mineral measurements. [abstract] J Bone Min Res 1(Suppl 1):A269, 1986.
10. Wasnich RD, Vogel JM, Ross PD, Heilbrun LK. Age-specific, longitudinal bone loss rates at multiple cortical and trabecular skeletal sites. [abstract] J Nucl Med 27(6):885, 1986.
11. Ross PD, Wasnich RD, Vogel JM, Hagino R, MacLean CJ. A model for the evaluation of costs and benefits associated with osteoporosis prevention strategies. [abstract] J Bone Min Res 2(suppl. 1):228, 1987.
12. Vogel JM, Wasnich RD, Ross PD. The relative influences of ethnicity, body size, and culture as determinants of bone mass. [abstract] J Bone Mine Res 2(suppl. 1):331, 1987.
13. Wasnich RD, Ross PD, Vogel JM, MacLean CJ. The relative strengths of osteoporotic risk factors in a prospective study of postmenopausal osteoporosis. [abstract] J Bone Min Res 2(suppl. 1):343, 1987.
14. Wasnich RD, Ross PD, Vogel JM. Patterns of cortical and trabecular bone loss related to age, ethnicity, and fracture risk. [abstract] J Nucl Med 28:752, 1987.
15. Wasnich RD, Davis JW, Ross PD, Vogel JM. The relative contributions of initial BMC and bone loss rates to fracture risk. [abstract] J Bone Min Res 3, (Supplement I):S87, 1988.
16. Ross RD, Wasnich RD, Heilbrun LK, Davis JW, Vogel JM. Methodologic considerations in osteoporosis research. [abstract] J Bone Min Res 3 (Supplement I):S123, 1988.
17. Davis JW, Ross PD, Wasnich RD, MacLean CJ, Vogel JM. The relationship of post-menopausal bone loss rates to bone mass. [abstract] J Bone Min Res 3 (Supplement I):S87, 1988.
18. Davis JW, Ross PD, Wasnich RD, MacLean CJ, Vogel JM. Comparison of cross-sectional and longitudinal measurements of age-related changes in bonemass. [abstract] J Bone Min Res 3 (Supplement I):S123, 1988.
19. Johnson NE, Kutch R, Davis JW, Ross PD, Wasnich RD. Diet and bone loss of Japanese American women. [abstract] Fed Proc, 1988.
20. Ross PD, Wasnich RD, Vogel JM. Sources of accuracy and precision errors in dual photon absorptiometry. [abstract] Calcif Tissue Int, 44:148, 1989.
21. Wasnich RD, Ross PD, MacLean CJ, Davis JW, Vogel JM. A prospective study of multi-site bone mineral measurements and spine fracture incidence. [abstract] Calcif Tissue Int, 44:152, 1989.
22. Ross PD, Wasnich RD, Davis JW, Vogel JM. Estimating remaining lifetime fracture probability from bone mineral measurements, age, and other factors. [abstract] J Bone Miner Res, 4(Suppl 1):S185, 1989.
23. Davis JW, Ross PD, Wasnich RD, Vogel JM. Age related changes in bone mineral content among elderly men. [abstract] J Bone Miner Res, 4(Suppl 1):S185, 1989.
24. Davis JW, Ross PD, Wasnich RD, Vogel JM. Long-term precision of measured bone loss rates among post-menopausal women. [abstract] J Bone Miner Res, 4(Suppl 1):S185, 1989.
25. Johnson NE, Kutch R, Davis J, Ross P, Wasnich R. The role of calcium in preventing bone loss. [abstract] J Bone Miner Res, 4(Suppl 1):S175, 1989.
26. Licata A, Jackson R, Miller P, Watts N, Harris S, Genant H, Wasnich R, Chesnut C. The effects of cyclical etidronate with or without phosphate in the treatment of postmenopausal osteoporosis: results of a multicenter study. [abstract] J Bone Miner Res, 4(suppl 1):S378, 1989.
27. Davis JW, Ross PD, Wasnich RD. Vogel JM. Age related changes in bone mineral content among elderly men. [abstract] J Bone Min Res 4 (Suppl 1):S185, 1989.
28. Ross PD, Wasnich RD, Davis JW, Vogel JM. Remaining lifetime fracture probability (RLFP): A comprehensive measure of fracture risk. [abstract] Calcif Tissue Inter 46:144, 1990.
29. Ross PD, Wasnich RD, Davis JW, Vogel JM. A comparison of vertebral dimensions between populations. [abstract] J Bone Miner Res 5(Suppl 2):S111, 1990.
30. Ross PD, Melton LJ III, Davis JW, Wasnich RD. Hip fracture incidence is lower in Japanese than in Caucasians. [abstract] J Bone Miner Res 5(Suppl 2):S111, 1990.
31. Wasnich RD, Davis JW, Ross PD, Vogel JM. Thiazides reduce bone loss rate among men. [abstract] J Bone Miner Res 5(Suppl 2):S113, 1990.
32. Ross PD, Davis JW, Yhee YK, Wasnich RD. Existing vertebral fractures greatly increase the risk of new vertebral fractures. [abstract] J Bone Miner Res 6(Suppl 1):S277, 1991.
33. Ross PD, Davis JW, Wasnich RD. Lower incidence of falls may explain why Japanese have fewer hip fractures than Caucasians. [abstract] J Bone Miner Res 6(Suppl 1):S277, 1991.
34. Wasnich RD. Bone mass measurements in diagnosis and assessment of therapy. [abstract] Osteoporosis Int 1(2):124-5, 1991.
35. Ross PD, Genant HK, White JM, Davis JW, Bevan JA, Miller P, Wasnich RD. Prediction of vertebral fracture incidence from baseline fractures and bone mass. [abstract] Bone Mineral 17(Suppl 1):140, 1992.
36. Wasnich RD, Davis JW, Ross PD. Both spine and non-spine prevalent fractures increase the risk of new spine fractures. [abstract] J Bone Miner Res 7(Suppl 1):S138, 1992.
37. Davis JW, Ross PD, Vogel JM, Wasnich RD. Effects of smoking and alcohol on the rates of bone loss among elderly Japanese-American men. [abstract] J Bone Miner Res 7(Suppl 1):S141, 1992.
38. Wasnich RD, Davis JW, He Y-F, Petrovich H, Ross PD. Thiazide reduces bone loss: a randomized double-blind, placebo controlled trial. [abstract] J Bone Miner Res 8(Suppl 1):S123, 1993.
39. Licata AA, Chesnut CH III, Genant HK, Harris ST, Jackson RD, Miller PD, Ross PD, Wasnich RD, Watts NB. Effects of 2 years' follow-up cyclical etidronate treatment in postmenopausal osteoporotic women. [abstract] J Bone Miner Res 8(Suppl 1):S141, 1993.
40. Davis JW, He Y-F, Ross PD, Wasnich RD. Calcium supplements improve the skeletal response to estrogen among elderly women. [abstract] J Bone Miner Res 8(Suppl 1):S331, 1993.
41. Huang C, Ross PD, He Y-F, Epstein RS, Lydick E, Yhee Y-K, Davis JW, Wasnich RD. Changes in vertebral deformity over time: a cohort study using various definitions of deformity. [abstract] J Bone Miner Res 8(Suppl 1):S336, 1993.
42. Miller PD, Jackson RD, Ross PD, Wasnich RD, Genant HK, Harris ST, Licata AA, Watts NB, Chestnut CH. ICT Etidronate for Osteoporosis: 5-year Results. [abstract] Bone Miner 25(Suppl 1):S74, 1994.
43. He Y-F, Ross PD, Davis JW, Epstein RS, Wasnich RD. A multi-state model for predicting vertebral fracture risk. [abstract] J Bone Miner Res 9(Suppl 1):S336, 1994.
44. Huang C, Imose K, Ross D, Davis JW, Wasnich RD. Bone density measured on hand x-rays predicts risk of vertebral fractures. [abstract] J Bone Miner Res 9(Suppl 1):S336, 1994.
45. Davis JW, Novotny R, Ross PD, Wasnich RD. The peak bone mass of Hawaiian, Filipino, Japanese, and Caucasian women in Hawaii. [abstract] J Bone Miner Res 9(Suppl 1):S331, 1994.
46. Fujiwara S, Huang C, Ross PD, Kodama K, Davis JW, Wasnich RD. Serum 25-hydroxyvitamin D levels are lower in Japan compared to US Japanese. [abstract] J Bone Miner Res 9(Suppl 1):S221, 1994.
47. Vogel JM, Huang C, Ross PD, Davis JW, Wasnich RD. Broadband ultrasound attenuation (BUA) predicts risk of vertebral fractures. [abstract] J Bone Miner Res 9(Suppl 1):S154, 1994.
48. Ross PD, Huang C, Davis JW, Wasnich RD. Vertebral dimensions improve prediction of vertebral fracture incidence. [abstract] J Bone Miner Res 9(Suppl 1):S130, 1994.
49. Ross PD, Huang C, Davis JW, Wasnich RD. A longitudinal study of pain and disability related to vertebral fractures. [abstract] Bone 16(Suppl 1):98S, 1995.
50. Ross PD, Huang C, Lydick E, Karpf D, Wasnich RD. Reproducibility of morphometric and visual vertebral fracture diagnosis. [abstract] Osteoporosis Int 5(4):311, 1995.
51. Watts NB, Miller PD, Licata AA, Jackson RD, Wasnich RD, Ross PD, Harris ST, Genant HK. Seven years of cyclical etidronate: continued improvement in spine BMD and progressive decline in vertebral fracture incidence. [abstract] Bone 17(6):617, 1995.
52. Wasnich RD, Davis J, Spencer K, Berger M, Gibb G, Ross PD. Impact of bone density screening upon prescriptions for osteoporosis. [abstract] Osteop Int 6(Suppl 1):201, 1996.
53. Ross PD, Coupland C, McClung M, Christiansen C, Wasnich RD, for the EPIC Study Group. Racial differences in bone density are not completely explained by differences in body size. [abstract] Osteop Int 6(Suppl 1):130, 1996.
54. Davis JW, Ross PD, Wasnich RD. Risk factors for falls among Japanese American women. [abstract] Osteop Int 6(Suppl 1):158, 1996.
55. Davis JW, Ross PD, Nevitt MC, Wasnich RD. Incidence rates of falls among Japanese-American men and women. [abstract] Osteop Int 6(Suppl 1):131, 1996.
56. Earnshaw SA, Keating NA, Hosking DJ, Chilvers CED, Ravn P, McClung M, Wasnich RD, for the EPIC Study Group. Dental status does not predict bone mineral density in early postmenopausal Caucasian women. [abstract] Osteop Int 6(Suppl 1):150, 1996.
57. Chesnut C III, Watts N, Miller P, Licata A, Jackson R, Wasnich R, Ross P, Harris S, Genant H, Schoenfeld S, Valent D. Cyclical etidronate: Efficacy and safety over seven years. [abstract] Osteop Int 6(Suppl 1):257, 1996.
58. Faulkner KG, McClung MR, Ravn P, Hosking D, Wasnich R, Daley M, Yates AJ for the EPIC Study Group. Monitoring skeletal response to therapy in early postmenopausal women: Which bone to measure? [abstract] J Bone Miner Res 11(Suppl 1):S96, 1996.
59. McClung MR, Faulkner KG, Ravn P, Hosking D, Wasnich R, Thompson D, Yates AJ for the EPIC Study Group. Inability of baseline biochemical markers to predict bone density changes in early postmenopausal women. [abstract] J Bone Miner Res 11(Suppl 1):S127, 1996.
60. Ross PD, Kim S, Wasnich RD. Bone density predicts vertebral fracture risk in both men and women: a prospective study. [abstract] J Bone Miner Res 11(Suppl 1):S127, 1996.
61. Huang C, Ross PD, Imose K, Wasnich RD. Long-term fracture prediction using bone density measurements: a prospective study. [abstract] J Bone Miner Res 11(Suppl 1):S365, 1996.
62. Wasnich, RD, Davis J, Spencer K, Berger M, Gibb G, Ross PD. The results of standardized fracture risk reporting upon physician prescribing patterns. [abstract] J Bone Miner Res 11(Suppl 1):S462, 1996.
63. Katagiri H, Ross PD, Aoyagi K, Huang C, Wasnich RD. Birth cohort differences in bone density disappear after adjustment for body size. [abstract] J Bone Miner Res 11(Suppl 1):S469, 1996.
64. Davis JW, Ross PD, Preston SD, Nevitt MC, Wasnich RD. Determinants of risk factors for falls and fractures among elderly women. [abstract] J Bone Miner Res 11(Suppl 1):S367, 1996.
65. Aoyagi K, Davis J, Ross P, Wasnich R, Hayashi T, Takemoto T. Lower fracture risk among Japanese may be related to lower frequency of falls. [abstract] J Bone Miner Res 11(Suppl 1):S155, 1996.
66. Hosking DJ, McClung MR, Ravn P, Wasnich RD, Thompson DE, Daley MS, Yates AJ, for the EPIC Study Group. Alendronate in the prevention of osteoporosis: EPIC study two-year results. [abstract] J Bone Miner Res 11(Suppl 1):S133, 1996.
67. Huang C, Ross PD, Wasnich RD. Vertebral fracture and other predictors of physical impairment and health care utilization. [extended abstract] Osteoporosis Digest, 1997 [in press]
68. Huang C, Ross PD, Yates AJ, Wasnich RD. Prediction of vertebral fracture by radiographic absorptiometry. [abstract] J Bone Miner Res 12(Suppl 1):S496, 1997.
69. Wasnich RD, Ross PD, Vogel JM. Comparison of pDEXA7 and SXA BMD of the radius. [abstract] J Bone Miner Res 12(Suppl 1):S378, 1997.
70. Ross PD, Wasnich RD, Knowlton WK. Skeletal alkaline phosphatase (Tandem7-R Ostase7) measurements predict vertebral fractures: A prospective study. [abstract] J Bone Miner Res 12(Suppl 1):S150, 1997.
71. Aoyagi K, Ross PD, Huang C, Davis J, Wasnich R, Hayashi R. Prevalence of joint pain is higher among native Japanese than Japanese-Americans. [abstract] J Bone Miner Res 12(Suppl 1):S512, 1997.
72. Hla M, Davis J, Ross P, Wasnich R, Yates J, Christiansen C, Hosking D, McClung M, EPIC Study Group. The relationship between body composition and biochemical markers of bone turnover in early postmenopausal women. [abstract] J Bone Miner Res 12(Suppl 1):S487, 1997.
73. Huang C, Ross PD, Davis JW, Imose K, Emi K, Wasnich RD. Prediction of single and multiple vertebral fractures by metacarpal BMD using Poisson regression. [abstract] J Bone Miner Res 12(Suppl 1):S496, 1997.
74. El Haji-Fuleihan G, Luckey M, Bauer R, Wasnich R, Krupa D, Reda C, Yates AJ, Daifotis for the alendronate Protocol 029 Study Group. Effects of discontinuation of alendronate in early postmenopausal women. [abstract] J Bone Miner Res 12(Suppl 1):S143, 1997.
75. Bidstrup ME, Ravn P, Bjarnason NH, Christiansen C, McClung MR, Hosking DJ, Wasnich R, Thompson DE, Daley MS, Yates AJ for the EPIC study group. Thin body build predicts rapid bone loss in postmenopausal women under age 60. [abstract] J Bone Miner Res 12(Suppl 1):S253, 1997.
